Get the tools used by (smart)2 investors.

Income Tax Expense CAGR (7y) for Johnson & Johnson

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

000943981: Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...

136.52 CHF
Price
CHF
Fair Value
Upside
128.66 - 150.15
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Johnson & Johnson's Income Tax Expense CAGR (7y):

HLTH.USPFEMRKBMYNVSANIP-30.0%-20.0%-10.0%0.0%

Performance Summary
  • Johnson & Johnson's income tax expense cagr (7y) is -23.0%

Benchmarks

Metric Usage: Income Tax Expense CAGR (7y)

Hide this widget
inc_tax_cagr_7y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Search for metric or datapoint

Income Tax Expense CAGR (7y)

Seven-year compound annual growth rate in provision for taxes.

Definition of Income Tax Expense CAGR (7y)

Hide this widget

Income Tax Expense CAGR (7y) measures the seven-year compound annual growth rate in Income Tax Expense.

Compound annual growth rate (CAGR) is a commonly used business and investing term that measures the growth of a metric over multiple periods. CAGRs are useful since they reduce the effect of volatility in specific periods, unlike arithmetic means.

You can find the calculation details for Johnson & Johnson’s Income Tax Expense CAGR outlined below. The calculation starts by listing values for Income Tax Expense for the last eight fiscal years that are required to calculate CAGR:

Johnson & Johnson's Income Tax Expense History
Fiscal YearIncome Tax ExpenseYoY Growth
2017-12-31T00:00:00.000Z16.373 B
2018-12-30T00:00:00.000Z2.702 B−83.5%
2019-12-29T00:00:00.000Z2.209 B−18.2%
2021-01-03T00:00:00.000Z1.783 B−19.3%
2022-01-02T00:00:00.000Z1.377 B−22.8%
2023-01-01T00:00:00.000Z2.989 B117.1%
2023-12-31T00:00:00.000Z1.736 B−41.9%
2024-12-29T00:00:00.000Z2.621 B51.0%

Using the values for Income Tax Expense listed in the table above, we can calculate three-year Income Tax Expense CAGR as follows:

 Number of years  =  7
 Multiplier       =  $2.621 B / $16.373 B  =  0.16
 7 Year CAGR     =  0.16 ^ (1/7) - 1  =  −23.0%

Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Johnson & Johnson’s reports in the USD currency. You can read more about Income Tax Expense here and compound annual growth rate on Wikipedia. You may also find variants three-year Income Tax Expense CAGR, and five-year Income Tax Expense CAGR useful.


Click the link below to download a spreadsheet with an example Income Tax Expense CAGR (7y) calculation for Johnson & Johnson below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-34.5%5.5%45.5%124.3%04080

The chart above depicts the distribution of income tax expense cagr (7y) for companies operating in the Healthcare sector in the Developed economic region. Over 580 companies were considered in this analysis, and 558 had meaningful values. The average income tax expense cagr (7y) of companies in the sector is 8.9% with a standard deviation of 26.8%.

Johnson & Johnson's Income Tax Expense CAGR (7y) of -23.0% ranks in the 7.7% percentile for the sector. The following table provides additional summary stats:

Income Tax Expense CAGR (7y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents582
Included Constituents558
Min-39.4%
Max121.4%
Median5.0%
Mean8.9%
Standard Deviation26.8%

You can find companies with similar income tax expense cagr (7y) using this stock screener.

All rights reserved. Terms Of Use